Advisors Asset Management Inc. Has $5.28 Million Stake in The Chemours Company $CC

Key Points

• Advisors Asset Management Inc. increased its stake in The Chemours Company by 65.8%, acquiring an additional 154,857 shares for a total of 390,095 shares worth approximately $5.3 million.
• Recent analyst ratings show a consensus of "Moderate Buy" for Chemours, with a price target adjustment ranging from $13.00 to $22.00 by multiple firms.
• CEO Denise Dignam purchased 4,068 shares at about $12.06 per share, increasing her ownership by 2.17% amidst ongoing shifts in institutional investor stakes and a dividend cut announcement.

Advisors Asset Management Inc. grew its holdings in The Chemours Company (NYSE:CC - Free Report) by 65.8% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 390,095 shares of the specialty chemicals company's stock after acquiring an additional 154,857 shares during the quarter. Advisors Asset Management Inc. owned 0.26% of Chemours worth $5,278,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of CC. Vanguard Group Inc. boosted its holdings in shares of Chemours by 8.3% in the first quarter. Vanguard Group Inc. now owns 16,487,008 shares of the specialty chemicals company's stock valued at $223,069,000 after buying an additional 1,263,047 shares during the period. Ameriprise Financial Inc. lifted its position in Chemours by 23.8% in the 4th quarter. Ameriprise Financial Inc. now owns 4,373,172 shares of the specialty chemicals company's stock valued at $73,907,000 after acquiring an additional 839,849 shares in the last quarter. Millennium Management LLC boosted its stake in Chemours by 44.6% in the 4th quarter. Millennium Management LLC now owns 2,507,262 shares of the specialty chemicals company's stock worth $42,373,000 after purchasing an additional 773,537 shares during the period. American Century Companies Inc. increased its holdings in Chemours by 17.5% during the 1st quarter. American Century Companies Inc. now owns 1,909,149 shares of the specialty chemicals company's stock worth $25,831,000 after purchasing an additional 284,130 shares in the last quarter. Finally, Vision One Management Partners LP increased its holdings in Chemours by 12.1% during the 4th quarter. Vision One Management Partners LP now owns 1,558,498 shares of the specialty chemicals company's stock worth $26,339,000 after purchasing an additional 168,148 shares in the last quarter. Institutional investors and hedge funds own 76.26% of the company's stock.

Chemours Stock Up 3.7%

CC traded up $0.56 during trading on Friday, reaching $15.65. 4,308,402 shares of the stock were exchanged, compared to its average volume of 3,434,551. The stock's 50 day moving average price is $13.73 and its two-hundred day moving average price is $12.72. The Chemours Company has a twelve month low of $9.13 and a twelve month high of $22.38. The stock has a market cap of $2.34 billion, a P/E ratio of -5.59 and a beta of 1.61. The company has a debt-to-equity ratio of 17.16, a quick ratio of 0.83 and a current ratio of 1.68.

Chemours (NYSE:CC - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The specialty chemicals company reported $0.58 earnings per share for the quarter, topping the consensus estimate of $0.46 by $0.12. The company had revenue of $1.62 billion for the quarter, compared to analyst estimates of $1.57 billion. Chemours had a negative net margin of 7.19% and a positive return on equity of 35.14%. Chemours's revenue for the quarter was up 5.0% compared to the same quarter last year. During the same period in the previous year, the business earned $0.38 EPS. Chemours has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. Equities analysts expect that The Chemours Company will post 2.03 EPS for the current year.

Chemours Cuts Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 12th. Investors of record on Friday, August 15th will be issued a dividend of $0.0875 per share. The ex-dividend date of this dividend is Friday, August 15th. This represents a $0.35 dividend on an annualized basis and a dividend yield of 2.2%. Chemours's payout ratio is presently -12.50%.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on CC shares. Barclays reduced their price objective on Chemours from $16.00 to $13.00 and set an "equal weight" rating for the company in a research report on Wednesday, May 28th. Wall Street Zen downgraded Chemours from a "hold" rating to a "sell" rating in a research report on Wednesday, May 21st. Morgan Stanley lowered their price objective on shares of Chemours from $22.00 to $15.00 and set an "equal weight" rating on the stock in a report on Monday, May 12th. Mizuho boosted their price objective on shares of Chemours from $13.00 to $16.00 and gave the stock an "outperform" rating in a research report on Tuesday, July 15th. Finally, Royal Bank Of Canada raised their target price on shares of Chemours from $14.00 to $15.00 and gave the company an "outperform" rating in a research report on Thursday, July 3rd. Five investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $17.38.

Insiders Place Their Bets

In other Chemours news, CEO Denise Dignam purchased 4,068 shares of the business's stock in a transaction on Friday, August 8th. The stock was acquired at an average price of $12.06 per share, with a total value of $49,060.08. Following the acquisition, the chief executive officer directly owned 191,546 shares of the company's stock, valued at $2,310,044.76. This trade represents a 2.17% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Company insiders own 0.34% of the company's stock.

Chemours Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.